Expertise

We have a wealth of expertise at the global, continental, national, regional, local, and hospital level. 

We have an understanding of the patient-centered and market access environments across the globe – our work often covers a global, US or European scope, and in addition, we also have extensive experience in supporting clients with projects in emerging markets throughout the world including Canada, China, India, Japan, Mexico, South Africa, South Korea, and many other countries throughout Africa, Central and South America, Asia and Australasia.

Health Economics & Data Analysis

We have a dedicated team of commercially-focused health economists and statisticians who interrogate, analyse and present economic and clinical data to support your product’s value proposition and steer it towards market access success. With vast experience across a broad range of project types, we use innovative research techniques to ensure our insights are clear and engaging. Expertise in R modelling as well as Excel, and the ability to develop standardized model structures with integrated software facilities for data manipulation, calculation and visualization, means we can provide tailored, flexible solutions to meet individual client and project needs.

To find out our expertise, click on one of the areas below

SPM case study – Hannah chased re: model outputs/results to be included (following LH email)

LEARN MORE

Elicitation of health state utilities across six global markets

LEARN MORE

Training and upskilling a client team on health economics

LEARN MORE

Defining the wider burden of illness to support the launch of a breakthrough oncology therapy in Europe

LEARN MORE

Understanding and communicating costs of the overall patient treatment pathway

LEARN MORE

Elicitation of health state disutilities associated with once-daily versus once-weekly injectable therapies in T2DM

LEARN MORE

Early cost-utility model to support product positioning and future HTA submissions

LEARN MORE

A network meta-analysis of randomised controlled trials in dementia with Lewy bodies

LEARN MORE

Model validation: Providing an external perspective to optimize economic modelling

LEARN MORE

Assessing the budget impact and cost-effectiveness of a treatment for a rare disease

LEARN MORE

Budget impact model to support inclusion of both adult and pediatric patients for an innovative oncology treatment

LEARN MORE

Key publications

Conference presentations